Intelligence / Healthtech / De Novo Grants / Smith & Nephew, Inc.
Approvalsnovel device granted (FDA De Novo)6 Jul 2026
Smith & Nephew, Inc.
6 Jul 2026: Novel device granted (FDA De Novo) · TESSA Spatial Surgery System; INTELLIO Tablet (72205455). Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 6 Jul 2026
- Device
- TESSA Spatial Surgery System; INTELLIO Tablet (72205455)
- Specialty
- Orthopedic
- Product Code
- SIQ
- Country
- United States
- Location
- Andover, MA
- Submitted
- 2025-08-22
- Reference
- DEN250037
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Smith & Nephew, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Smith & Nephew, Inc. in our registers.
27 OctSmith & Nephew, Inc.device cleared · HealthtechApprovals23 OctSmith & Nephew, Inc.device cleared · HealthtechApprovals8 SeptSmith & Nephew, Inc.device cleared · HealthtechApprovals11 NovSmith & Nephew, INC.Class II recall · HealthtechQuality28 OctSmith & Nephew, Inc.trial registered · HealthtechClinical
More in Orthopedic
De Novo Grants
21 AugBrixton Biosciencesnovel device granted (FDA De Novo) · ReneuRx (Neural Ice)Approvals17 JulStryker Endoscopynovel device granted (FDA De Novo) · SportSuite Vision SoftwareApprovals17 JunFziomed, Inc.novel device granted (FDA De Novo) · Oxiplex®Approvals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.